These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9189907)

  • 1. Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome.
    Farrer MJ; Crayton L; Davies GE; Oliver C; Powell J; Holland AJ; Kessling AM
    Neuroreport; 1997 May; 8(7):1645-9. PubMed ID: 9189907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the amyloid precursor protein locus on dementia in Down syndrome.
    Margallo-Lana M; Morris CM; Gibson AM; Tan AL; Kay DW; Tyrer SP; Moore BP; Ballard CG
    Neurology; 2004 Jun; 62(11):1996-8. PubMed ID: 15184603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.
    Lee JH; Lee AJ; Dang LH; Pang D; Kisselev S; Krinsky-McHale SJ; Zigman WB; Luchsinger JA; Silverman W; Tycko B; Clark LN; Schupf N
    Neurobiol Aging; 2017 Aug; 56():150-158. PubMed ID: 28554490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects.
    Del Bo R; Comi GP; Giorda R; Crimi M; Locatelli F; Martinelli-Boneschi F; Pozzoli U; Castelli E; Bresolin N; Scarlato G
    J Neurol; 2003 Jun; 250(6):688-92. PubMed ID: 12796830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE2 allele, Down's syndrome, and dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts GW
    Ann N Y Acad Sci; 1996 Jan; 777():255-9. PubMed ID: 8624094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E allele distribution in trisomy 13, 18, and 21 conceptuses in a Hungarian population.
    Nagy B; Bán Z; Tóth-Pál E; Papp C; Fintor L; Papp Z
    Am J Clin Pathol; 2000 Apr; 113(4):535-8. PubMed ID: 10761455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis.
    Prasher VP; Chowdhury TA; Rowe BR; Bain SC
    Am J Ment Retard; 1997 Sep; 102(2):103-10. PubMed ID: 9327086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
    JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gender difference in the association between APOE genotype and age-related cognitive decline.
    Mortensen EL; Høgh P
    Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [APOE gene polymorphisms associated with Down syndrome in Colombian populations].
    Rengifo L; Gaviria D; Serrano H
    Biomedica; 2012 Jun; 32(2):224-32. PubMed ID: 23242296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
    Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
    J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.